Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp
Start free

Longeveron Inc. (LGVN) Balance Sheet

As of 2026-06-30 (10-Q), Longeveron Inc. (LGVN) reported total assets of $15.5M, total liabilities of $5.1M and shareholders' equity of $10.4M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $10.1M.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

LGVNLongeveron Inc.Follow LGVN — free
Drug Manufacturers - General · Healthcare
—
Price chart with a free account
Market cap
5.1M
P/E TTM
—
Dividend yield
—
52-week
—
Next earnings
4 Nov, in 10 days
LineFY2021
Dec 21
FY2022
Dec 22
FY2023
Dec 23
FY2024
Dec 24
FY2025
Dec 25
Latest
Jun 26
Trend
Cash and equivalents25.710.54.919.24.710.1
Short-term investments9.49.20.40.0——
Receivables0.10.20.10.10.10.1
Current assets35.420.35.819.65.511.3
Total assets42.827.412.125.610.315.5
Current liabilities2.74.93.92.64.14.3
Total liabilities5.36.95.33.74.65.1
Shareholders' equity37.520.56.721.95.710.4

USD millions · SEC XBRL

Longeveron Inc. — questions

How much cash does Longeveron Inc. have?
$10.1M in cash and cash equivalents as of 2026-06-30.
What are Longeveron Inc.'s total assets?
$15.5M as of 2026-06-30.
What is Longeveron Inc.'s shareholders' equity?
$10.4M as of 2026-06-30.

Every figure on this page comes from Longeveron Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.